Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
News Archive
News Archive Navigation
News Archive Navigation Language
February 2018
-
Taking on obesity
Novartis is developing an experimental drug for weight loss.
-
Potential weight loss treatment takes shape with help from patients
Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.
-
Compound designed to fight Alzheimer’s disease shows promise in the lab
The molecule restores the activity of neurons and neural circuits in a model of the disease.
-
Partnering for improved cancer care around the globe
Novartis works tirelessly with third-party organizations to improve access to cancer care.
-
Living with breast cancer in Uganda
Suzan Akello describes what life has been like since her cancer diagnosis.
January 2018
-
Tracking patients’ progress with radio signals and machine learning
Novartis researchers leverage in-house startup initiative to begin digital technology research collaboration.
-
Organic dealmaker for drug discovery
New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.
-
Open science demystified
Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.
December 2017
-
Pioneering business approach expands healthcare in Indian villages
Healthy Family program combines health education with improved access to doctors and medicines.
-
One boy’s quest to battle cancer
After a diagnosis of childhood cancer, Ryan faced the diagnosis and treatment of leukemia head- on with the support of his family and community.
-
Researchers overcome hurdles to test experimental malaria drug
The race is on to find a new treatment before resistance to today’s drugs becomes widespread.
Pagination
- ‹ Previous page
- 1
- …
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- …
- 32
- › Next page